Looking Into NGM Biopharmaceuticals’s Recent Short Interest
NGM Biopharmaceuticals’s (NYSE:NGM) short percent of float has fallen 34.39% since its last report. The company recently reported…
Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session.
NGM Bio Announces Clinical Data From Trial Of NGM707 In Advanced Solid Tumors And Outlines Evolved Strategy For Aldafermin And NGM120
Encouraging findings in heavily pretreated patients in multiple solid tumor indications, including MSS colorectal cancer (CRC), in ongoing Phase 1 Part 1b study evaluating NGM707, a dual ILT2/ILT4 antagonist antibody, in
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Longboard Pharmaceuticals (NASDAQ:LBPH) shares moved upwards by 200.7% to $18.13 during Tuesday’s regular session. The company’s market…
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers Longboard Pharmaceuticals (NASDAQ:LBPH) shares increased by 157.0% to $15.5 during Tuesday’s pre-market session. The market value of…
Ngm Biopharmaceuticals Confirmed It Received A Non-Binding Expression Of Interest From The Column Group Regarding Potential Acquisition Of All Outstanding Shares Of Common Stock Of The Company Not Already Owned By TCQ In A Going-Private Transaction
NGM Biopharmaceuticals, Inc. ("NGM Bio" or the "Company") today confirmed that it has received a non-bindingexpression of interest dated December 28, 2023 (the "EOI") from The Column Group,
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers NGM Biopharmaceuticals (NASDAQ:NGM) shares moved upwards by 43.2% to $1.23 during Monday’s after-market session. The company’s market…
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Strata Skin Sciences (NASDAQ:SSKN) shares moved upwards by 60.0% to $0.88 during Friday’s after-market session. The company’s…
B. Riley Securities Maintains Buy Rating for NGM Biopharmaceuticals: Here’s What You Need To Know
B. Riley Securities has decided to maintain its Buy rating of NGM Biopharmaceuticals (NASDAQ:NGM) and lower its price…